We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+13.06%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.23B
AUM Growth
+$208M
Cap. Flow
+$191M
Cap. Flow %
4.51%
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$383M
2
DFS
Discover Financial Services
DFS
+$224M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$183M
4
WBA
Walgreens Boots Alliance
WBA
+$110M
5
JWN
Nordstrom
JWN
+$95.8M

Top Sells

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$235M
2
SMAR
Smartsheet Inc.
SMAR
+$216M
3
EDR
Endeavor Group Holdings, Inc.
EDR
+$144M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$103M
5
ALTR
Altair Engineering Inc
ALTR
+$97.9M

Sector Composition

Rank Sector Weight
1 Energy 17.21%
2 Healthcare 16.93%
3 Financials 12.93%
4 Industrials 12.5%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPT
251
PUT
Medical Properties Trust
MPT
$2.75B
$129K ﹤0.01%
396,500
– –
OCUL icon
252
CALL
Ocular Therapeutix
OCUL
$1.92B
$123K ﹤0.01%
+120,000
New +$922K
SLNO
253
CALL
DELISTED
Soleno Therapeutics
SLNO
$123K ﹤0.01%
15,000
+5,000
+50% +$243K
F icon
254
PUT
Ford
F
$55B
$115K ﹤0.01%
195,500
-325,400
-62% -$3.18M
AMC icon
255
AMC Entertainment Holdings
AMC
$2.29B
$114K ﹤0.01%
39,688
-36,306
-48% -$119K
VISN
256
CALL
Vistance Networks Inc
VISN
$2.33B
$113K ﹤0.01%
+450,000
New +$2.39M
ERAS icon
257
Erasca
ERAS
$6.34B
$104K ﹤0.01%
75,627
-153,973
-67% -$264K
VERA icon
258
CALL
Vera Therapeutics
VERA
$2.3B
$103K ﹤0.01%
40,000
+25,000
+167% +$803K
KPTI icon
259
Karyopharm Therapeutics
KPTI
$44.2M
$88.4K ﹤0.01%
23,640
-75,275
-76% -$643K
TPH
260
PUT
DELISTED
Tri Pointe Homes
TPH
$85.5K ﹤0.01%
+18,000
New +$614K
CCL icon
261
PUT
Carnival Corporation Ltd
CCL
$39.4B
$83.4K ﹤0.01%
120,000
-380,000
-76% -$9.04M
EVLVW
262
DELISTED
Evolv Technologies Warrant
EVLVW
$77K ﹤0.01%
463,341
– –
YARW
263
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$72K ﹤0.01%
911
-4,005
-81% -$493K
QQQ icon
264
PUT
Invesco QQQ Trust
QQQ
$479B
$71.8K ﹤0.01%
+16,000
New +$8.13M
INCY icon
265
CALL
Incyte
INCY
$24B
$70.8K ﹤0.01%
55,000
+35,000
+175% +$2.44M
CLBR.WS
266
DELISTED
Colombier Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
CLBR.WS
$69.3K ﹤0.01%
90,000
-10,000
-10% -$9.04K
CRVS icon
267
Corvus Pharmaceuticals
CRVS
$1.17B
$66.3K ﹤0.01%
20,850
-19,150
-48% -$90.2K
CCCC icon
268
C4 Therapeutics
CCCC
$402M
$63.8K ﹤0.01%
39,868
-97,492
-71% -$291K
BGS icon
269
PUT
B&G Foods
BGS
$278M
$59.6K ﹤0.01%
113,600
-3,900
-3% -$26K
XFOR icon
270
X4 Pharmaceuticals
XFOR
$393M
$59.6K ﹤0.01%
8,420
-33,725
-80% -$465K
IFRX icon
271
InflaRx
IFRX
$253M
$59.2K ﹤0.01%
58,073
-567,516
-91% -$1.07M
AER icon
272
CALL
AerCap
AER
$24.4B
$59.1K ﹤0.01%
+112,500
New +$11.1M
SYF icon
273
PUT
Synchrony
SYF
$25.6B
$57.5K ﹤0.01%
21,900
– –
IMUX icon
274
Immunic
IMUX
$198M
$53.3K ﹤0.01%
4,887
-15,571
-76% -$168K
AES icon
275
CALL
AES
AES
$10.5B
$52.5K ﹤0.01%
+150,000
New +$1.74M
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q1 2025 Portfolio in Review

As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

UBS O'Connor deployed $191M of net new capital in Q1 2025, opening 83 new positions and adding to 81 existing holdings. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Juniper Networks, an estimated $71.4M trimmed.

  • UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
  • UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
  • UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
  • UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
  • UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
  • UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
  • UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.